Molecular staging of non-small cell lung cancer according to K-ras genotypes

Clinical Cancer Research

Volumn 2, Issue 6, 1996, Pages 1083-1086

  Rosell, Rafael ^a   Monzó, Mariano ^a   Pifarré, Alex ^a   Ariza, Aurelio ^a   Sánchez, José Javier ^b   Moreno, Isabel ^a   Maurel, Joan ^a   López, Maria Paz ^a   Abad, Albert ^a   De Anta, Josep Maria ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 8944237972     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Barbacid, M. Ras genes. Annu. Rev. Biochem , 56: 779-827, 1987.
2. Peinado, M. A., Fernandez-Renart, M., Capella, G., Wilson, L., and Perucho, M. Mutations in the p53 suppressor gene do not correlate with c-K-ras oncogene mutations in colorectal cancer. Int. J. Oncol., 2: 123-134, 1993.
3. Finkelstein, S. D., Sayegh, R., Bakker, A., and Swalsky, P. Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch. Surg., 128: 526-532, 1993.
4. Rodenhuis, S., and Slebos, R J. C. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res., 52 (Suppl. 9):2 665S-2669S, 1992.
5. Rosell, R., Gómez-Codina, J., Camps, C., Maestre, J., Padilla, J., Cantó, A., Mate, J. L., Li, S., Roig, J., Olazábal, A., Canela, M., Ariza, A., Skácel, Z., Morera-Prat J., and Abad, A. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N. Engl. J. Med., 330: 153-158, 1994.
6. Roth, J A., Fossella, F., Komaki, R., Ryan, M. B., Putnam, J. B., Jr., Lee, J. S., Dhingra, H., De Caro, L., Chasen, M., McGavran, M., Atkinson, E. N., and Hong, W. K. J. Natl. Cancer Inst., 86: 673-680, 1994
7. Rosell, R., Li, S., Skácel, Z., Mate, J. L., Maestre, J., Canela, M., Tolosa, E., Armengol, P., Barnadas, A., and Ariza, A. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Oncogene, 8: 2407-2412, 1993.
8. Sugio, K., Ishida, T., Yokoyama, H , Inoue, T., Sugimachi, K., and Sasazuki, T. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res., 52: 2903-2906, 1992.
9. Mountain, C. F. A new international staging system for lung cancer. Chest, 89 (Suppl. 4): 225S-233S, 1986.
10. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-81, 1958.
11. Miller, R. G., Jr. Survival Analysis, pp. 44-102. New York: John Wiley, 1981.
12. Cox, D. R. Regression models and life-tables. J. R. Stat. Soc. [B], 34: 187-220, 1972.
13. Vachtenheim, J., Horáková, I., Novotná, H., Opálka, P., and Roubková, H. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Clin. Cancer Res., 1: 359-365, 1995.
14. Slebos, R. J. C., Kibbelaar, R E., Dalesio, O., Kooistra, A., Stam, J., Meijer, C. J. L. M., Wagenaar, S. S., Vanderschueren, R. G. J. R. A., van Zandwijk, N., Mooi, W. J., Bos, J. L., and Rodenhuis, S. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med., 323: 561-565, 1990.
15. Mitsudomi, T., Steinberg, S. M., Oie, H. K., Mulshine, J. L., Phelps, R., Viallet, J., Pass, H., Minna, J. D., and Gazdar, A. F. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res., 51: 4999-5002, 1991.
16. Kern, J. A., Slebos, R. J. C., Top, B., Rodenhuis, S., Lager, D., Robinson, R. A., Weiner, D., and Schwartz, D. A. c-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J. Clin. Invest., 93: 516-520, 1994.
17. Bongiorno, P. F., Whyte, R. I., Lesser, E. J., Moore, J. H., Orringer, M. B., and Beer, D. G. Alteration of K-ras, p53 and erbB-2/neu in human lung adenocarcinoma. J. Thorac. Cardiovasc. Surg., 107: 590-595, 1994.
18. Carbone, D. P., Mitsudomi, T., Chiba, I., Piantadosi, S., Rusch, V., Nowak, J A., McIntire, D., Slamon, D., Gazdar, A., and Minna, J. p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871. Chest, 106 (Suppl.): 377-381, 1994.
19. Ridanpää, M., Karjalainen, A, Anttila, S., Vainio, H., and Husgafvel-Pursiainen, K. Genetic alterations in p53 and K-ras in lung cancer in relation to histopathology of the tumor and smoking history of the patient. Int. J. Oncol., 5: 1109-1117, 1994.
20. Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., and Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (Lond.), 363: 558-561, 1993.
21. Shridar, V., Siegfried, J., Hunt, J., Alonso, M. M., and Smith, D. I. Genetic instability of microsatellite sequences in many non-small cell lung carcinomas. Cancer Res., 54: 2084-2087, 1994.